Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension

Guido Grassi, Fosca Quarti-Trevano, Giuseppe Mancia

Research output: Contribution to journalArticlepeer-review


The development of angiotensin II receptor blockers (ARB) as a new class of drugs for the management of hypertension has elicited the attention of many clinicians worldwide with the aim of improving blood pressure (BP) control as well as cardiovascular protection.Among ARB telmisartan has been shown to be characterised by an antihypertensive efficacy fully covering the 24-hour period, thereby allowing to antagonise the adverse effects of early morning BP rise on cardiovascular risk. Other specific effects of the drug are represented by its favourable metabolic profile (particularly on insulin sensitivity) and neutral effects on sympathetic cardiovascular function. These properties are coupled with cardioprotective effects, documented by the evidence that the drug: 1) is effective in favouring the regression of cardiac and vascular organ damage, 2) reduces arterial stiffness and improves vascular distensibility and 3) reverses the endothelial dysfunction typical of the hypertensive state particularly when complicated by renal failure, diabetes, obesity or metabolic syndrome. Several of these properties can account for the results of the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET), documenting the beneficial effects on the drug on cardiovascular morbidity and mortality.

Original languageEnglish
Pages (from-to)66-74
Number of pages9
JournalJRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Issue number2
Publication statusPublished - Jun 2008


  • 24-hour ambulatory blood pressure monitoring
  • Angiotensia II receptor antagonists
  • Blood pressure control
  • Cardiac protection
  • Endothelial function
  • Insulin resistance
  • Left ventricular hypertrophy
  • Traget organ damage
  • Vascular protection

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine


Dive into the research topics of 'Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension'. Together they form a unique fingerprint.

Cite this